
Transpek Industry (TRANSPEK) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.5B
Gross Profit
775.5M
50.28%
Operating Income
117.3M
7.60%
Net Income
155.8M
10.10%
EPS (Diluted)
₹27.90
Balance Sheet Metrics
Total Assets
10.0B
Total Liabilities
2.6B
Shareholders Equity
7.5B
Debt to Equity
0.34
Cash Flow Metrics
Revenue & Profitability Trend
Transpek Industry Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 6.5B | 5.8B | 8.3B | 6.0B | 3.4B |
Cost of Goods Sold | 3.3B | 3.0B | 4.5B | 3.2B | 1.7B |
Gross Profit | 3.2B | 2.8B | 3.8B | 2.8B | 1.7B |
Gross Margin % | 48.8% | 48.6% | 45.8% | 46.2% | 50.1% |
Operating Expenses | |||||
Research & Development | - | 14.3M | 15.2M | 11.7M | 9.0M |
Selling, General & Administrative | - | 539.4M | 736.7M | 494.1M | 239.6M |
Other Operating Expenses | 1.6B | 820.3M | 851.4M | 720.4M | 518.8M |
Total Operating Expenses | 1.6B | 1.4B | 1.6B | 1.2B | 767.4M |
Operating Income | 446.9M | 517.4M | 1.3B | 768.4M | 258.9M |
Operating Margin % | 6.9% | 8.9% | 15.9% | 12.8% | 7.6% |
Non-Operating Items | |||||
Interest Income | - | 33.8M | 16.1M | 15.8M | 6.1M |
Interest Expense | 117.4M | 119.0M | 154.1M | 73.1M | 85.0M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 616.6M | 555.1M | 1.1B | 842.4M | 255.4M |
Income Tax | 129.2M | 169.5M | 293.2M | 188.4M | 22.3M |
Effective Tax Rate % | 21.0% | 30.5% | 26.0% | 22.4% | 8.7% |
Net Income | 487.4M | 385.6M | 834.8M | 654.0M | 233.1M |
Net Margin % | 7.5% | 6.7% | 10.1% | 10.9% | 6.9% |
Key Metrics | |||||
EBITDA | 1.2B | 1.0B | 1.6B | 1.2B | 608.5M |
EPS (Basic) | ₹87.25 | ₹69.03 | ₹149.45 | ₹117.09 | ₹41.74 |
EPS (Diluted) | ₹87.25 | ₹69.03 | ₹149.45 | ₹117.09 | ₹41.74 |
Basic Shares Outstanding | 5585903 | 5585569 | 5585569 | 5585569 | 5585569 |
Diluted Shares Outstanding | 5585903 | 5585569 | 5585569 | 5585569 | 5585569 |
Income Statement Trend
Transpek Industry Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 565.2M | 80.8M | 55.0M | 16.0M | 154.8M |
Short-term Investments | 483.3M | 215.9M | 192.8M | 488.2M | 60.1M |
Accounts Receivable | 1.0B | 918.6M | 1.2B | 991.8M | 761.2M |
Inventory | 671.3M | 643.5M | 652.3M | 661.5M | 367.2M |
Other Current Assets | 265.8M | 73.0K | 7.9M | 10.1M | 4.3M |
Total Current Assets | 3.0B | 2.1B | 2.3B | 2.4B | 1.5B |
Non-Current Assets | |||||
Property, Plant & Equipment | 3.6B | 300.4M | 268.2M | 265.9M | 369.1M |
Goodwill | 177.0K | 186.0K | 195.0K | 204.0K | 213.0K |
Intangible Assets | 177.0K | 186.0K | 195.0K | 204.0K | 213.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 17.4M | -7.0K | -10.0K | -11.0K | -105.0K |
Total Non-Current Assets | 7.0B | 7.5B | 6.5B | 5.2B | 4.5B |
Total Assets | 10.0B | 9.7B | 8.9B | 7.6B | 6.0B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 636.7M | 457.9M | 543.1M | 564.0M | 361.5M |
Short-term Debt | 416.3M | 505.7M | 635.2M | 960.9M | 594.7M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 39.4M | 24.7M | - | 26.5M | 1.0K |
Total Current Liabilities | 1.2B | 1.1B | 1.4B | 1.7B | 1.1B |
Non-Current Liabilities | |||||
Long-term Debt | 528.3M | 722.7M | 813.7M | 409.6M | 513.8M |
Deferred Tax Liabilities | 773.0M | 1.0B | 799.7M | 698.3M | 584.8M |
Other Non-Current Liabilities | - | - | 1.0K | 1.0K | 1.0K |
Total Non-Current Liabilities | 1.3B | 1.8B | 1.6B | 1.1B | 1.1B |
Total Liabilities | 2.6B | 2.9B | 3.0B | 2.8B | 2.2B |
Equity | |||||
Common Stock | 56.4M | 55.9M | 55.9M | 55.9M | 55.9M |
Retained Earnings | - | 3.8B | 3.6B | 2.9B | 2.3B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 7.5B | 6.7B | 5.9B | 4.8B | 3.8B |
Key Metrics | |||||
Total Debt | 944.5M | 1.2B | 1.4B | 1.4B | 1.1B |
Working Capital | 1.8B | 1.0B | 987.9M | 783.0M | 472.7M |
Balance Sheet Composition
Transpek Industry Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 616.6M | 555.1M | 1.1B | 842.4M | 255.4M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 67.0M | 212.6M | -243.1M | -701.8M | -44.1M |
Operating Cash Flow | 747.4M | 874.6M | 1.1B | 230.2M | 302.7M |
Investing Activities | |||||
Capital Expenditures | -189.4M | -380.4M | -445.5M | -379.1M | -144.2M |
Acquisitions | 0 | 0 | 0 | 0 | 0 |
Investment Purchases | - | - | - | -427.4M | -60.7M |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -187.2M | -382.6M | -446.6M | -806.0M | -204.3M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -78.2M | -153.6M | -125.7M | -41.9M | -14.0M |
Debt Issuance | 8.7M | - | - | 0 | 96.0M |
Debt Repayment | -81.6M | -156.8M | -507.3M | -95.0M | -99.3M |
Financing Cash Flow | -232.7M | -388.5M | -1.1B | 303.0M | 163.2M |
Free Cash Flow | 1.1B | 581.6M | 615.2M | -5.9M | 169.8M |
Net Change in Cash | 327.6M | 103.5M | -453.8M | -272.8M | 261.5M |
Cash Flow Trend
Transpek Industry Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.40
Forward P/E
20.12
Price to Book
1.14
Price to Sales
1.30
PEG Ratio
20.12
Profitability Ratios
Profit Margin
8.44%
Operating Margin
7.60%
Return on Equity
6.54%
Return on Assets
4.87%
Financial Health
Current Ratio
2.47
Debt to Equity
12.67
Beta
-0.25
Per Share Data
EPS (TTM)
₹98.47
Book Value per Share
₹1,331.51
Revenue per Share
₹1,167.69
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
transpek | 8.5B | 15.40 | 1.14 | 6.54% | 8.44% | 12.67 |
Deepak Nitrite | 254.3B | 36.47 | 4.72 | 13.61% | 8.42% | 23.36 |
Navin Fluorine | 245.8B | 67.38 | 9.07 | 10.99% | 13.90% | 55.85 |
Styrenix Performance | 48.5B | 20.62 | 4.15 | 24.88% | 7.89% | 34.02 |
Gujarat Alkalies | 42.3B | 70.12 | 0.70 | -1.08% | -0.82% | 9.30 |
Foseco India Limited | 30.6B | 37.26 | 8.27 | 24.30% | 14.05% | 0.42 |
Financial data is updated regularly. All figures are in the company's reporting currency.